We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.88T
1-Year Est. Return 44.46%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+0.67%
1 Year Est. Return
+44.46%
3 Year Est. Return
+136.69%
5 Year Est. Return
+180.19%
10 Year Est. Return
+697.06%
AUM
$743B
AUM Growth
+$17B
Cap. Flow
+$20.9B
Cap. Flow %
2.82%
Top 10 Hldgs %
22.73%
Holding
4,944
New
223
Increased
2,961
Reduced
1,210
Closed
86

Top Buys

Rank Stock Value
1
MRNA icon
Moderna
MRNA
+$887M
2
AMZN icon
Amazon
AMZN
+$857M
3
AAPL icon
Apple
AAPL
+$844M
4
MSFT icon
Microsoft
MSFT
+$802M
5
TSLA icon
Tesla
TSLA
+$606M

Sector Composition

Rank Sector Weight
1 Technology 24.53%
2 Financials 13.97%
3 Healthcare 13.42%
4 Consumer Discretionary 11.85%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NGCA
4051
DELISTED
NextGen Acquisition Corp. II Class A Ordinary Shares
NGCA
$476K ﹤0.01%
48,111
NAII icon
4052
Natural Alternatives International
NAII
$13.2M
$474K ﹤0.01%
35,195
+568
+2% +$9.41K
NWG icon
4053
NatWest
NWG
$76.6B
$474K ﹤0.01%
72,312
+1,801
+3% +$11.2K
SCPH
4054
DELISTED
scPharmaceuticals
SCPH
$473K ﹤0.01%
71,223
+4,748
+7% +$28.4K
UBOH
4055
DELISTED
United Bancshares Inc/OH
UBOH
$473K ﹤0.01%
15,511
+1,015
+7% +$33.3K
STCN
4056
DELISTED
Steel Connect, Inc. Common Stock
STCN
$472K ﹤0.01%
24,924
CELU icon
4057
Celularity
CELU
$20.4M
$471K ﹤0.01%
+6,655
New +$537K
NXDR
4058
Nextdoor Holdings
NXDR
$998M
$471K ﹤0.01%
46,324
AUBN icon
4059
Auburn National Bancorp
AUBN
$91.1M
$470K ﹤0.01%
13,833
-2
-0% -$69
SLNH icon
4060
Soluna Holdings
SLNH
$208M
$470K ﹤0.01%
2,346
+1,447
+161% +$291K
ISUN
4061
DELISTED
iSun, Inc. Common Stock
ISUN
$468K ﹤0.01%
56,451
+9,844
+21% +$88.4K
MACK
4062
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$467K ﹤0.01%
96,692
LSTA icon
4063
Lisata Therapeutics
LSTA
$9.91M
$466K ﹤0.01%
25,477
+642
+3% +$12.6K
SUNE
4064
SUNation Energy
SUNE
$10.8M
0
OGEN icon
4065
Oragenics
OGEN
$2.42M
$464K ﹤0.01%
406
RGLS
4066
DELISTED
Regulus Therapeutics
RGLS
$463K ﹤0.01%
67,075
+8,155
+14% +$59.7K
VOOG icon
4067
Vanguard S&P 500 Growth ETF
VOOG
$27.4B
0
STSA
4068
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$460K ﹤0.01%
98,803
+25,403
+35% +$135K
VANI icon
4069
Vivani Medical
VANI
$120M
$459K ﹤0.01%
48,059
-783
-2% -$8.82K
CBUS icon
4070
Cibus
CBUS
$147M
$458K ﹤0.01%
2,718
+49
+2% +$9.48K
DXYN
4071
DELISTED
Dixie Group Inc
DXYN
$458K ﹤0.01%
94,427
+15,033
+19% +$58.7K
CWBR
4072
DELISTED
CohBar, Inc. Common Stock
CWBR
$456K ﹤0.01%
15,865
+3,889
+32% +$140K
AGFS
4073
DELISTED
AgroFresh Solutions Inc
AGFS
$456K ﹤0.01%
211,134
+1,941
+0.9% +$3.92K
ASRV icon
4074
AmeriServ Financial
ASRV
$84.3M
$454K ﹤0.01%
116,261
-2,070
-2% -$7.95K
PALI icon
4075
Palisade Bio
PALI
$366M
$454K ﹤0.01%
229
+196
+594% +$433K

Similar funds

Geode Capital Management's Q3 2021 Portfolio in Review

As of Q3 2021, Geode Capital Management held 4,944 positions worth $743B, up 2.3% from $726B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Geode Capital Management's Q3 2021 filing shows 223 new, 2,961 increased, 1,210 reduced and 86 closed positions. Its largest new stake was Lucid Motors: 565,353 shares worth $143M. The largest sale was Alexion Pharmaceuticals, an estimated $760M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q3 2021 buy was Lucid Motors: 565,353 shares worth $143M.
  • Geode Capital Management added most to Moderna in Q3 2021, an estimated $887M increase.
  • Geode Capital Management's biggest Q3 2021 reduction was Oracle, cutting an estimated $126M.
  • Geode Capital Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $760M.
  • Geode Capital Management's ten largest holdings make up 23% of its $743B portfolio in Q3 2021.
  • Geode Capital Management opened 223 new positions and closed 86 in Q3 2021.
  • Geode Capital Management's portfolio value rose 2.3% quarter-over-quarter to $743B.

Based on Geode Capital Management's 13F filing for Q3 2021, filed 12 Nov 2021.